Bluefin Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-330,900
Closed -$3.35M 814
2019
Q3
$3.35M Buy
330,900
+89,100
+37% +$8.47M 0.49% 39
2019
Q2
$1.73M Sell
241,800
-1,277,300
-84% -$121M 0.24% 67
2019
Q1
$10.4M Buy
+1,519,100
New +$133M 1.51% 7

Other funds holding CELG

Bluefin Capital Management's CELG Position: Q4 2019 in Review

Bluefin Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,223 shares — an estimated $1.61M sold.

Bluefin Capital Management first reported a position in CELG in Q2 2015 and held it in 7 quarters. The position peaked at $6.48M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bluefin Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bluefin Capital Management sold 16,223 Celgene Corp shares in Q4 2019, an estimated $1.61M.
  • Bluefin Capital Management first reported a position in Celgene Corp in Q2 2015 and held it in 7 quarters.
  • Bluefin Capital Management's Celgene Corp position peaked at $6.48M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bluefin Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.